To include your compound in the COVID-19 Resource Center, submit it here.

PG11047: Completed Phase Ib enrollment

Progen completed enrollment of 172 patients in an open-label, dose-escalation, U.S. Phase Ib trial

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE